Le H. Song1,2,*, Nguyen T. Xuan1,*, Nguyen L. Toan1,3, Vu Q. Binh3, Angelica B. Boldt1, Peter G. Kremsner1, Jürgen F. J. Kun1
European Cytokine Network, Vol.19, No.4, pp. 204-210, 2008, DOI:10.1684/ecn.2008.0137
Abstract Interferon-α (IFNα) is a critical mediator of immunity to hepatitis B virus (HBV) infection.
Although IFN has been used in the treatment of viral hepatitis for more than a decade, the role of IFN-α-receptor
in HBV infection has not been intensively studied. We have evaluated the impact of two variants of
the IFNAR1 gene on the outcome of HBV infection. Four hundred and fifty eight HBV-infected Vietnamese
patients, with well-characterised clinical profiles including all forms of hepatic disease, and 160 non-infected,
healthy Vietnamese individuals were enrolled in the study. Of these patients, 54 had acute… More >